Description

3-[7-[[3-Carboxy-2,4,6-Triiodo-5-(Methylcarbamoyl)Phenyl]Carbamoyl]Heptanoylamino]-2,4,6-Triiodo-5-(Methylcarbamoyl)Benzoic Acid is a high-purity, non-ionic iodinated organic compound designed for advanced diagnostic applications. Its molecular structure provides excellent radiopacity and biocompatibility, making it a critical intermediate in the synthesis of modern X-ray and CT contrast media. This product is essential for pharmaceutical manufacturers and research institutions developing next-generation diagnostic agents.

Application

• Pharmaceutical Intermediate: Primary building block for synthesizing non-ionic iodinated contrast agents used in medical imaging.
• X-ray & CT Contrast Media: Key precursor for agents that enhance vascular and organ visualization in diagnostic radiology.
• Research & Development: Used in academic and industrial labs for developing novel diagnostic compounds and studying structure-activity relationships.
• Chemical Synthesis: Serves as a versatile intermediate for further chemical modifications due to its reactive carboxylic acid and amide functional groups.
• Quality Control Reference Standard: Employed as an analytical standard to ensure the purity and consistency of final contrast agent formulations.

Basic Information

Product Name	3-[7-[[3-Carboxy-2,4,6-Triiodo-5-(Methylcarbamoyl)Phenyl]Carbamoyl]Heptanoylamino]-2,4,6-Triiodo-5-(Methylcarbamoyl)Benzoic Acid
CAS No.	10397-76-9
Molecular Formula	C25H21I6N4O8
Molecular Weight	1266.78 g/mol
Synonyms	Ioxaglic Acid Impurity; Ioxaglate Intermediate; 3,3'-(Heptanedioylbis(imino-3,1-phenylene-2,4,6-triiodo-5,1-phenylene))bis(2-methyl-2-propenoic acid) derivative; 5,5'-(Heptanedioylbis(imino-3,1-phenylene-2,4,6-triiodo-3,1-phenylene))bis(2-methyl-2-oxazoline-4-carboxylic acid) related compound; Hexabrix intermediate; Non-ionic dimeric contrast agent precursor; Ioxaglic acid related compound A; CAS 10397-76-9
EINECS	Contact for details

Quality Control

Our 3-[7-[[3-Carboxy-2,4,6-Triiodo-5-(Methylcarbamoyl)Phenyl]Carbamoyl]Heptanoylamino]-2,4,6-Triiodo-5-(Methylcarbamoyl)Benzoic Acid is manufactured under strict quality systems. It undergoes rigorous analytical testing, including HPLC, NMR, and elemental analysis, to ensure it meets the high-purity standards required for pharmaceutical intermediates. Certificates of Analysis (COA) are provided with each batch, detailing purity, identity, and impurity profiles to support your regulatory and R&D needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which can affect stability and handling properties.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines
Heavy Metals	≤ 20 ppm
Loss on Drying	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.